Article

Surgeon recommends firms manufacture IOLs in 0.25 D steps

It would be helpful if IOL manufacturers made lenses available in 0.25 D steps and provided more detailed information regarding the optical design since refractive outcomes can now be predicted more accurately.

It would be helpful if IOL manufacturers made lenses available in 0.25 D steps and provided more detailed information regarding the optical design since refractive outcomes can now be predicted more accurately, according to Thomas Olsen from the University Eye Clinic, Aarhus Hospital, Denmark.

Dr Olsen obtained the refractive results from several thousand IOL implantations using optical biometry and compared them with the predictions made using regression methods, thick lens vergence methods and exact ray tracing methods. In each case the predictions were based on previously described true ACD-prediction algorithms.

It was discovered that thick lens vergence and exact ray tracing methods are more effective than regression methods and that refractive outcomes can be predicted accurately well below 0.5 D, which is the current power availability step.

The results indicate that it would be useful if IOLs were available in 0.25 D steps.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.